SEC Form 4 · accession 0001209191-18-043884
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Essig
Director
Period of report
Jul 23, 2018
Accepted (ET)
Jul 25, 2018 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 23, 2018 | M | 19,448 | $21.12 | A | 1,438,367 | D | |
| Common StockF2 | Jul 23, 2018 | S | 19,448 | $63.5023 | D | 1,418,919 | D | |
| Common Stock | Jul 24, 2018 | M | 50,423 | $21.12 | A | 1,469,342 | D | |
| Common StockF3 | Jul 24, 2018 | S | 50,423 | $63.5576 | D | 1,418,919 | D | |
| Common Stock | holding | — | — | — | 608,700 | I | By GRAT |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $21.12 | Jul 23, 2018 | M | 19,448 | D | — | Aug 14, 2018 | Common Stock | 19,448 | 50,423 | D |
| Non-Qualified Stock Option (right to buy)F4 | $21.12 | Jul 24, 2018 | M | 50,423 | D | — | Aug 14, 2018 | Common Stock | 50,423 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- F2The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $63.50 to $63.55.
- F3The price shown above represents the weighted average price of the shares sold. The range of sale prices was $63.50 to $63.625.
- F425% of the option grant vested on 8/14/2009 (the first anniversary of the grant date of 8/14/2008), and the remaining 75% vested monthly thereafter over 36 months.